Inhibitory Effect of Phosphorothioate Oligonucleotide Complementary to G6PD mRNA on Murine Melanoma
In terms of the incidence among all tumors, skin cancer is on top, with the most deadly among them being melanoma. The search for new therapeutic agents to combat melanoma is very relevant. In our opinion, antisense oligonucleotides (ASO) aimed at suppressing the genes responsible for their viability in cancer cells give hope for treatment, which makes it possible to eliminate cancer cells near the tumor site both before and after surgery. In this article, we describe how Skeen-11 phosphorothioate oligonucleotide significantly decreased the proliferative activity of murine melanoma cells. Injections of Skeen-11 also inhibited tumor growth in mice with inoculated melanoma. A toxicity study showed no side effects with dose adjustments. The results show that the use of ASO Skeen-11 in vivo reduced the tumor size within 7 days, reduced the number of mitoses in the tumor cells, and increased the amount of necrosis compared with the control group.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:45 |
|---|---|
| Enthalten in: |
Current issues in molecular biology - 45(2023), 4 vom: 06. Apr., Seite 3180-3192 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Yurchenko, Kseniya A [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cancer |
|---|
| Anmerkungen: |
Date Revised 17.05.2023 published: Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3390/cimb45040207 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM356884171 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM356884171 | ||
| 003 | DE-627 | ||
| 005 | 20231226071416.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/cimb45040207 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1189.xml |
| 035 | |a (DE-627)NLM356884171 | ||
| 035 | |a (NLM)37185731 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Yurchenko, Kseniya A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Inhibitory Effect of Phosphorothioate Oligonucleotide Complementary to G6PD mRNA on Murine Melanoma |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 17.05.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a In terms of the incidence among all tumors, skin cancer is on top, with the most deadly among them being melanoma. The search for new therapeutic agents to combat melanoma is very relevant. In our opinion, antisense oligonucleotides (ASO) aimed at suppressing the genes responsible for their viability in cancer cells give hope for treatment, which makes it possible to eliminate cancer cells near the tumor site both before and after surgery. In this article, we describe how Skeen-11 phosphorothioate oligonucleotide significantly decreased the proliferative activity of murine melanoma cells. Injections of Skeen-11 also inhibited tumor growth in mice with inoculated melanoma. A toxicity study showed no side effects with dose adjustments. The results show that the use of ASO Skeen-11 in vivo reduced the tumor size within 7 days, reduced the number of mitoses in the tumor cells, and increased the amount of necrosis compared with the control group | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a cancer | |
| 650 | 4 | |a cell proliferation | |
| 650 | 4 | |a glucose-6-phosphate dehydrogenase | |
| 650 | 4 | |a melanoma | |
| 650 | 4 | |a phosphorothioate oligonucleotides | |
| 700 | 1 | |a Laikova, Kateryna V |e verfasserin |4 aut | |
| 700 | 1 | |a Golovkin, Ilya O |e verfasserin |4 aut | |
| 700 | 1 | |a Novikov, Ilya A |e verfasserin |4 aut | |
| 700 | 1 | |a Yurchenko, Alyona A |e verfasserin |4 aut | |
| 700 | 1 | |a Makalish, Tatyana P |e verfasserin |4 aut | |
| 700 | 1 | |a Oberemok, Volodymyr V |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current issues in molecular biology |d 1999 |g 45(2023), 4 vom: 06. Apr., Seite 3180-3192 |w (DE-627)NLM113667744 |x 1467-3045 |7 nnns |
| 773 | 1 | 8 | |g volume:45 |g year:2023 |g number:4 |g day:06 |g month:04 |g pages:3180-3192 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3390/cimb45040207 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 45 |j 2023 |e 4 |b 06 |c 04 |h 3180-3192 | ||